...
PHGELARGE

BiomX Inc.

HealthcareBiotechnology
$6.30
$0.03(+50.18%)
52W$1.56
$14.71
Updated Mar 5, 12:00 AM
RSI51
RS Rating93/99
Beta0.93
Volatility149%
F-Score3/9
Mkt Cap$82.8B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

BiomX Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 93), indicating clear outperformance against the broad market. Earnings contraction of 6% provides fundamental context to the price action. However, price is extended 57% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
93
out of 99
Market Leader
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.93
vs S&P 500
MARKET
52W Position
36%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$4.00
50 SMA > 100 SMA$5.54
100 SMA > 150 SMA$6.96
150 SMA > 200 SMA$7.40

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$5.12+22.94%ABOVE
50 SMA$4.00+57.48%ABOVE
100 SMA$5.54+13.81%ABOVE
150 SMA$6.96-9.52%BELOW
200 SMA$7.40-14.82%BELOW

Price Performance

1D+50.2%
1W+37.9%
1M+38.2%
3M+21.9%
6M-35.8%
YTD+194.4%
1Y-48.8%
3Y-59.1%
52-Week Trading Range36% from low
$6.30
52W Low$1.56
52W High$14.71

Technical Indicators

RSI (14)NEUTRAL
51.0
305070
VCP ScoreCOOL
5/10
Base depth: 110.2%

Risk Profile

Beta
0.93
52W Vol
149%
ATR
$0.82
Max DD (1Y)
-87%

Volume Analysis

Today
126.2K
50D Avg
1.26M
Vol Ratio
0.10x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24+33%
$-0.80
Q1'25+99%
$-0.33
Q2'25+73%
$-0.19
Q3'25-6%
$0.29
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+96.49%

Stock Price CAGR

10 Years:-43.30%
5 Years:-65.75%
3 Years:-59.11%
1 Year:-48.82%

Return on Equity

10Y Avg:-84.5%
5Y Avg:-108.2%
3Y Avg:-143.3%
Last Year:-356.4%

Key Metrics

Market Cap$82.8B
Gross Margin
Net Margin
Piotroski F-Score3/9

Frequently Asked Questions

Is PHGE in an uptrend right now?

PHGE has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is PHGE overbought or oversold?

PHGE's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.

Is PHGE outperforming the market?

PHGE has a Relative Strength (RS) Rating of 93 out of 99. Yes, PHGE is a market leader, outperforming 93% of all stocks over the past 12 months.

Where is PHGE in its 52-week range?

PHGE is trading at $6.30, which is 43% of its 52-week high ($14.71) and 36% above its 52-week low ($1.56).

How volatile is PHGE?

PHGE has a Beta of 0.93 and 52-week volatility of 149%. It's less volatile than the S&P 500 - generally more stable.